Stay updated on Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.

Latest updates to the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page
- ChecktodayChange DetectedA new line '2023 ( U.S. NIH Grant/Contract )' has been added to the study's external identifiers, indicating NIH funding for this trial. This provides visibility into the study's funding source within the record.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating the content has been updated to a newer revision.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, updating the page’s revision label. This is a minor metadata change and does not alter the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision tag was updated to v3.6.3, reflecting a metadata update to the study record. This appears to be a maintenance change rather than a substantive modification to study details or content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a backend/content-management update. No visible changes to the study details or layout are introduced.SummaryDifference0.0%

- Check65 days agoChange DetectedThe sponsor name on the study record was updated from Swedish Orphan Biovitrum AB to Swedish Orphan Biovitrum, aligning with the current corporate branding. This update reflects the official sponsor attribution in the study details.SummaryDifference0.0%

Stay in the know with updates to Pegcetacoplan in TA-TMA post-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in TA-TMA post-HSCT Clinical Trial page.